S'abonner

Identification of matrix metalloproteinase-9 in amniotic fluid and amniochorion in spontaneous labor and after experimental intrauterine infection or interleukin-1? infusion in pregnant rhesus monkeys - 02/09/11

Doi : 10.1067/mob.2002.118916 
Felipe Vadillo-Ortega, MD, PhDa, Drew W. Sadowsky, PhDb, George J. Haluska, PhDb, Cesar Hernandez-Guerrero, PhDa, Rebeca Guevara-Silva, BSca, Michael G. Gravett, MDb,c, Miles J. Novy, MDb,c
Mexico City, Mexico, and Beaverton and Portland, Ore 
From the Department of Research Direction and Electron Microscopy, Instituto Nacional de Perinatologíaa; the Division of Reproductive Science, Oregon Regional Primate Research Centerb; and the Department of Obstetrics and Gynecology, Oregon Health and Science University.c 

Abstract

Objective: The purpose of this study was to examine the roles of intrauterine infection, inflammation, and spontaneous labor on the expression of matrix metalloproteinase-9 in fetal membranes and amniotic fluid of late pregnant rhesus monkeys. Study Design: Pregnant rhesus monkeys with timed gestations were chronically catheterized to allow serial sampling of amniotic fluid before and during experimentally induced intrauterine inflammation. Six animals received group B streptococci into the chorionic-decidual space, and 4 animals received intra-amniotic interleukin-1β infusions (10 μg). Three additional animals were serially sampled by amniocentesis through late pregnancy until spontaneous term labor. Amniotic fluid samples were examined by zymography for matrix metalloproteinase-9 and -2 and Western immunoblot for matrix metalloproteinase-9 and -2 and tissue inhibitors of metalloproteinase-1 and -2. Fetal membranes were obtained at cesarean delivery during labor (before rupture), formalin fixed, and embedded in paraffin for immunocytochemistry of matrix metalloproteinase-9 and in situ hybridization of matrix metalloproteinase-9 messenger RNA. Tissues from 2 additional animals were collected as age-matched nonlabor controls. Results: In amniotic fluid, the 92-kd latent matrix metalloproteinase-9 was detectable in late pregnancy and increased dramatically, followed by the appearance of the 83-kd active form before spontaneous term delivery. Amniotic fluid matrix metalloproteinase-2 levels (both latent and active forms) remained relatively constant throughout pregnancy and in labor. Both bacteria and interleukin-1β rapidly increased the signal of latent matrix metalloproteinase-9 without a consistent increase in the active form before the onset of labor. Chorionic-decidual inoculation of group B streptococci was followed by the expression of latent matrix metalloproteinase-9 before the appearance of group B streptococci in amniotic fluid or the onset of labor. Matrix metalloproteinase-2 increased to a new steady-state level or remained unchanged after group B streptococci inoculation or interleukin-1β infusion, respectively. Amniotic fluid tissue inhibitors of metalloproteinase-1 declined and tissue inhibitors of metalloproteinase-2 remained unchanged during early group B streptococci infection, after interleukin-1β infusion and on the day of spontaneous term labor. However, both tissue inhibitors of metalloproteinase-1 and -2 levels increased after preterm labor that was induced by group B streptococci. Immunocytochemistry localized matrix metalloproteinase-9 protein to amnion and chorion epithelial and mesenchymal cells and decidual stromal cells. Granular matrix metalloproteinase-9 staining was observed in the connective tissue layer of inflamed fetal membranes. In situ hybridization for messenger RNA confirmed the production of matrix metalloproteinase-9 by amnion and chorion. Conclusion: Bacterial- and interleukin-1β–induced preterm labor and spontaneous term labor are preceded and accompanied by progressive increases in amniotic fluid matrix metalloproteinase-9 (92 kd) in rhesus monkeys. Amniotic fluid matrix metalloproteinase-9 may serve as a clinical marker for the onset of both preterm and term labor. (Am J Obstet Gynecol 2002;186:128–38.)

Le texte complet de cet article est disponible en PDF.

Keywords : Matrix metalloproteinases, gelatinase B, MMP-9, intrauterine infection, preterm labor, rhesus monkey


Plan


 Supported by grants HD06159 and HD 18185 from the National Institute of Child Health and Human Development, grant A142490 from the National Institute of Allergy and Infectious Diseases, and grant RR00163 from the National Institutes of Health. F.V-O. was supported by a Fogarty Fellowship (TW00668) and by the McArthur Foundation.
☆☆ Reprint requests: Miles J. Novy, MD, Division of Reproductive Sciences, Oregon Regional Primate Research Center, 505 NW 185th Ave, Beaverton, OR 97006. E-mail: gibbinsc@ohsu.edu.


© 2002  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 186 - N° 1

P. 128-138 - janvier 2002 Retour au numéro
Article précédent Article précédent
  • Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome
  • Rekha Bajoria, Stuart Ward, Ratna Chatterjee
| Article suivant Article suivant
  • Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome
  • Jiri D. Sonek, Kypros H. Nicolaides

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.